<http://webisa.webdatacommons.org/253224421>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/133228535>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/253224421> .
<http://webisa.webdatacommons.org/253224421>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<patentdocs.org> .
<http://webisa.webdatacommons.org/prov/135508721>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/253224421> .
<http://webisa.webdatacommons.org/253224421>	<http://www.w3.org/ns/prov#value>	"Here, Myriad distinguishes the isolated BRCA 1 and BRCA 2 genes as being unavailable to scientists for any use, including the detection and treatment of breast and other cancers." .